Mucormycosis Infection
The
infection caused by fungi in order of mucorales is defined as Mucormycosis Infection. Most common
species involved in causing this type of
infection are Rhizopus rhizomucor, cunninghamella, apophysomyces, saksenaea, absidia, muccor, and syncephal astrum. The major route of
infection is through inhalation, ingestion and traumatic inoculation. The various types of Mucormycosis
Infection are rhinocerebral Mucormycosis, pulmonary Mucormycosis, cutaneous Mucormycosis, gastrointestinal mucormycosis and disseminated mucormycosis. The miscallaneous forms of
infection are endocarditis, pyelonephritis drug users, bones, mediastinum, kidneys, peritone um.in patients with dialysis. High suspicion required in the treatment of Mucormycosis Infection. Mucormycosis workup involves biopsy-of involved tissue, swabs of tissue discharge are unreliable, CBC for neutropenia, ABG to correct acidosis and RBS-sugar control.
High Impact List of Articles
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Assessing the turn over time of critical value in hospitals
Mohan CK, Sugathan NV and Chandraja CV
Opinion Article: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Updated review of nilotinib as frontline treament for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia
Massimo Breccia, Matteo Molica & Giulina Alimena
Drug Evaluation: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
Relevant Topics in Clinical